5-Bromo-1,3-Thiazole

In the synthesis of substituted thiazole pharmacophores targeting tyrosine kinase inhibition, 5-bromo-1,3-thiazole serves as a strategic electrophilic partner in palladium-mediated cross-coupling. A representative protocol for the construction of 5-aryl-1,3-thiazole intermediates involves charge of the bromide (1.0 eq), arylboronic acid (1.2–1.5 eq), and 2 mol% Pd(PPh₃)₄ into a rigorously degassed mixture of 1,4-dioxane and aqueous 2 M K₂CO₃ (3:1 v/v). The batch is heated to 85±2°C under argon for 12–16 hours, with reaction progress monitored by HPLC (C18 column, 254 nm). Upon completion, the cooled mixture is filtered through a Celite pad, diluted with ethyl acetate, and washed with brine. The organic layer is concentrated under reduced pressure below 40°C to avoid thermal dehalogenation. The crude residue is purified by flash chromatography on silica gel (hexane/EtOAc gradient) to afford the 5-arylthiazole in 78–92% isolated yield. For compounds requiring subsequent amidation to yield clinical kinase inhibitor backbones—such as those resembling the N-(2-chloro-6-methylphenyl)-2-aminothiazole-5-carboxamide motif—the 5-aryl intermediate is converted to the carboxylic acid via metal-halogen exchange. Specifically, treatment with 1.05 eq of n-BuLi in anhydrous THF at –78°C, followed by CO₂ bubbling and acidification, furnishes the crystalline acid after recrystallization from acetonitrile. When scaling beyond 50 kg batch size, a jacketed 500 L glass-lined reactor with a double mechanical seal is employed; the temperature ramp during lithiation must not exceed 3°C/min to suppress ring-opening side reactions. TOC analysis of waste streams is held below 500 mg/L to comply with local discharge permits. The final drug intermediate typically requires ≥99.5% purity as determined by HPLC area normalization and must conform to residual metal limits per USP <232> / <233> and ICH Q3D. Residual solvents are controlled within ICH Q3C concentration thresholds; for instance, dioxane is maintained below 380 ppm. The resulting thiazole intermediate is packaged under nitrogen in LDPE-lined aluminium foil bags and stored at 2–8°C to prevent dimerization.

SDHI Fungicide Build Block: Process-Scale Coupling and Purity Profiles

5-Bromo-1,3-thiazole is extensively employed as a starting material in the manufacture of succinate dehydrogenase inhibitor (SDHI) fungicide candidates containing a 5-substituted thiazole-2-carboxamide warhead. A typical production route on 2000 L scale uses a biphasic Suzuki-Miyaura coupling in a dimpled jacket vessel equipped with a pitched-blade turbine. The reaction charges thiazole bromide (100 kg, 0.61 kmol), arylboronic acid (1.15 eq), potassium carbonate (2.5 eq), and 0.8 mol% PEPPSI-IPr catalyst in a 4:1 toluene/water mixture at 65°C. Agitation at 150 rpm ensures droplet dispersion, while jacket water temperature is maintained within ±1.5°C through a closed-loop PID controller. The reaction endpoint is confirmed by GC analysis (DB-5 column, 15 m, FID) showing residual bromide <0.5%. The organic phase is separated and subjected to vacuum distillation (45 mbar, jacket 70°C) to strip toluene. The crude amine-free product is then dissolved in hot isopropanol, treated with 2 wt% activated carbon (Norit SX+) at 60°C for 30 min, and hot-filtered. The filtrate is seeded at 55°C and cooled at 0.15°C/min to 5°C, yielding off-white crystalline 5-arylthiazole. Isolated purity by GC area % exceeds 98.5%, with individual organic impurities capped at 0.15%. In-process controls include Karl Fischer titration ensuring water content after crystallization is below 0.3%, critical for downstream amidation with sulfonyl chlorides. The material is then converted to the final SDHI fungicide active ingredient in a subsequent step involving hydrolysis and coupling with 2-(trifluoromethyl)benzenesulfonamide. The full technical-grade active ingredient must conform to FAO Specification 581 and CIPAC method MT 30.5. A comparative impurity profile is outlined below.

The environmental fate class of the resulting fungicide dictates that photolytic degradation studies follow OECD 316, and acute toxicity testing aligns with EPA OCSPP 870.1100. Production campaigns often integrate solvent recovery systems achieving >97% toluene recycle, and palladium scavenging resin cartridges (Smopex-234) are installed in-line to reduce metal discharge below publicly reported threshold limits.

Organic light-emitting diode (OLED) emissive layer materials incorporating electron-deficient thiazole units demand ultra-high-purity 5-bromo-1,3-thiazole as a common building block for Suzuki- or Stille-type polymerizations. The bromide is copolymerized with distannyl-thiophene or diboronic ester comonomers using 0.25 mol% Pd₂(dba)₃ and 1.0 mol% P(o-tolyl)₃ in anhydrous chlorobenzene at 130°C under strict argon cover. The crude polymer is precipitated into methanol, washed with aqueous EDTA (0.1 M) to strip palladium, and subjected to Soxhlet extraction with acetone for 48 hours to remove low-molecular-weight oligomers. The isolated poly(thiazole-alt-thiophene) exhibits a number-average molecular weight Mₙ of 15–35 kDa (GPC in THF, polystyrene standards) and a polydispersity index ≤ 1.8. For device fabrication, the polymer is further purified by train sublimation in a four-zone gradient furnace at pressures below 10⁻⁶ Torr. Zone temperatures are set at 180°C, 220°C, 250°C, and a deposition zone at 25°C. This process reduces volatile halide residuals: discharge analysis by combustion ion chromatography (EN 14582) requires bromine content ≤ 5 ppm and palladium ≤ 0.5 ppm, since excess halogen quenches excitons and induces device degradation at luminance above 1000 cd/m². The sublimed material is transferred directly to a glovebox (H₂O <0.1 ppm, O₂ <1 ppm) and formulated into inks for ink-jet printing of pixilated AMOLED substrates. Film morphology is assessed by atomic force microscopy (RMS roughness <0.5 nm over 10×10 µm scan area). The finished polymer batch is released for device fabrication only when current efficiency in a test stack (ITO/PEDOT:PSS/polymer/Ca/Al) exceeds 8.5 cd/A at 500 cd/m² operating brightness. Quality assurance protocols reference SEMI C7.5-1019 for chemical purity grades of organic luminescent materials, and every production lot carries a certificate of analysis reporting metal content by HR-ICP-MS with detection limits at parts-per-trillion for Fe, Cu, and Zn, as these trace metals promote non-radiative recombination.

When 5-Bromo-1,3-Thiazole Undergoes Lithiation to Form Electron-Poor Phosphine Ligands

Sterically and electronically tuned heterocyclic phosphine ligands for Group 10 metal catalysis are accessed via halogen-metal exchange on 5-bromo-1,3-thiazole. In a nitrogen-flushed 20 L jacketed vessel equipped with a cryogenic probe, anhydrous THF (8 L) is cooled to –95°C using liquid nitrogen/ethanol circulation. The bromide (500 g, 3.05 mol) is dissolved in an additional 2 L of THF and dosed into the reactor over 45 min while 1.6 M n-BuLi in hexanes (2.0 L, 1.05 eq) is added simultaneously via a second dosing pump. The controlled addition maintains an internal temperature below –90°C; a deviation above –85°C triggers automatic shut-off and quenching with pre-chilled methanol because 5-thiazolyllithium undergoes rapid ring fragmentation. The resulting deep red solution is stirred for 30 min before neat chlorodiisopropylphosphine (460 g, 1.05 eq) is introduced neat over 20 min, causing immediate decolorization. The mixture is warmed to ambient temperature over 4 hours, quenched with degassed 5% NaHCO₃, and extracted with degassed toluene. After drying over molecular sieves (3Å, activated at 300°C under vacuum), the solvent is removed in vacuo and the residue distilled under high vacuum (bp 78–82°C at 0.05 Torr) to yield 5-diisopropylphosphino-1,3-thiazole as a colorless, pyrophoric liquid. ³¹P NMR (202 MHz, C₆D₆) shows a singlet at −8.9 ppm. This ligand, when combined with Pd₂(dba)₃ in a 1:1 molar ratio, catalyzes the Buchwald-Hartwig amination of aryl chlorides with primary amines at a loading of 0.5 mol% Pd, achieving turnover frequencies above 1200 h⁻¹ at 100°C. The ligand must be stored in sealed ampoules under argon at −20°C; exposure to air beyond 50 ppm O₂ leads to oxidation to the corresponding phosphine oxide within minutes. End-use applications are found in the manufacture of unsymmetrical triarylamine hole transport materials for perovskite solar cells, where the thiazole moiety imparts a reduced HOMO level (−5.4 eV vs. vacuum) that improves open-circuit voltage. Because the ligand synthesis feeds directly into the final device material stream, residual lithium and iron from n-BuLi handling are controlled: ICP-OES analysis of the final hole transport layer blend must return Li <0.1 ppm and Fe <0.05 ppm to avoid carrier trapping. Compliance with IEC 62321-7-2:2017 is observed when these materials enter display or photovoltaic supply chains.

High-quantum-yield small-molecule fluorophores for live-cell imaging are constructed around a 5-ethynyl-1,3-thiazole core obtained from 5-bromo-1,3-thiazole via Sonogashira coupling. Anhydrous triethylamine (20 eq) is simultaneously used as base and co-solvent in the presence of 3 mol% Pd(PPh₃)₂Cl₂ and 6 mol% CuI at 60°C; a terminal alkyne carrying a protected carboxyphenyl or naphthalimide reporter is introduced at 1.2 eq. The reaction is intensely sensitive to molecular oxygen, requiring a minimum of five vacuum-argon cycles. After coupling, the crude product is purified by column chromatography (silica gel 60Å, CH₂Cl₂/MeOH 98:2) to remove unreacted alkyne and copper residues. A subsequent treatment with a thiol-functionalized polystyrene scavenger (QuadraPure TU) under gentle rotation at 40°C for 8 hours reduces residual copper below 0.5 ppm as measured by GF-AAS. This step is non-negotiable because the final fluorescent probe is designed as a Cu²⁺-selective “turn-off” sensor, and background copper contamination would elevate the baseline quenching constant. The probe exhibits excitation λₘₐₓ at 385 nm and emission λₑₘ at 445 nm in PBS buffer (pH 7.4), with a Stern–Volmer quenching constant for Cu²⁺ of 8.2×10⁴ M⁻¹. For intracellular application, the compound is first validated by MTT assay according to ISO 10993-5:2009, confirming >90% cell viability at 10 µM. Packaging for shipment of this research-grade chemical involves amber borosilicate vials under argon with PTFE-lined caps, labelled in accordance with CLP Regulation (EC) 1272/2008. Stability data indicate that the agent must be stored at –20°C and protected from light; under these conditions, HPLC purity remains >97% after 12 months. Published data for this specific configuration is limited, but the general class of 5-arylethynylthiazoles has demonstrated two-photon absorption cross-sections suitable for deep-tissue imaging.